Literature DB >> 15694329

GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal.

Elena E Bagley1, Michelle B Gerke, Christopher W Vaughan, Stephen P Hack, MacDonald J Christie.   

Abstract

Adaptations in neurons of the midbrain periaqueductal gray (PAG) induced by chronic morphine treatment mediate expression of many signs of opioid withdrawal. The abnormally elevated action potential rate of opioid-sensitive PAG neurons is a likely cellular mechanism for withdrawal expression. We report here that opioid withdrawal in vitro induced an opioid-sensitive cation current that was mediated by the GABA transporter-1 (GAT-1) and required activation of protein kinase A (PKA) for its expression. Inhibition of GAT-1 or PKA also prevented withdrawal-induced hyperexcitation of PAG neurons. Our findings indicate that GAT-1 currents can directly increase the action potential rates of neurons and that GAT-1 may be a target for therapy to alleviate opioid-withdrawal symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694329     DOI: 10.1016/j.neuron.2004.12.049

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  32 in total

1.  75 years of opioid research: the exciting but vain quest for the Holy Grail.

Authors:  Alistair D Corbett; Graeme Henderson; Alexander T McKnight; Stewart J Paterson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod bipolar cells.

Authors:  Eric Wersinger; Yannick Schwab; José-Alain Sahel; Alvaro Rendon; David V Pow; Serge Picaud; Michel J Roux
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

3.  Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal.

Authors:  Aya Matsui; Brooke C Jarvie; Brooks G Robinson; Shane T Hentges; John T Williams
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

Review 4.  Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.

Authors:  M J Christie
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

5.  Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors.

Authors:  Elena E Bagley; Jennifer Hacker; Vladimir I Chefer; Christophe Mallet; Gavan P McNally; Billy C H Chieng; Julie Perroud; Toni S Shippenberg; MacDonald J Christie
Journal:  Nat Neurosci       Date:  2011-10-30       Impact factor: 24.884

6.  Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance.

Authors:  Adrianne R Wilson-Poe; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  J Physiol       Date:  2017-09-07       Impact factor: 5.182

7.  Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.

Authors:  Emma E Johnson; Billy Chieng; Ian Napier; Mark Connor
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

8.  Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.

Authors:  Leon W Fyfe; Daniel R Cleary; Tara A Macey; Michael M Morgan; Susan L Ingram
Journal:  J Pharmacol Exp Ther       Date:  2010-08-25       Impact factor: 4.030

9.  micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal.

Authors:  Anuradha Madhavan; Li He; Garret D Stuber; Antonello Bonci; Jennifer L Whistler
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

10.  Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission.

Authors:  Lucia Carvelli; Randy D Blakely; Louis J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.